In patients with prostate cancer, high expression of USP39 predicts poor prognosis and USP39 promotes tumorigenesis of prostate cancer cells via promoting EGFR mRNA maturation and transcription elongation [10]. The gene discussed is USP39; the disease is prostate cancer.